Trade

Orchid Pharma share price

Balanced risk
  • 42%Low risk
  • 42%Moderate risk
  • 42%Balanced risk
  • 42%High risk
  • 42%Extreme risk
  • ₹917.00(7.57%)
    June 12, 2026 15:51:59 PM IST
    • NSE
    • BSE
  • Vol : 531.75 K (NSE + BSE)
    Last 20 day avg : 132.48 K

Orchid Pharma is trading 7.57% upper at Rs 917.00 as compared to its last closing price. Orchid Pharma has been trading in the price range of 933.50 & 847.00. Orchid Pharma has given 11.46% in this year & 1.33% in the last 5 days. Orchid Pharma has TTM P/E ratio 122.18 as compared to the sector P/E of 26.87.There are 1 analysts who have initiated coverage on Orchid Pharma. There are 1 analysts who have given it a strong buy rating & 0.00 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 23.78 Crores in its last quarter.Listed peers of Orchid Pharma include Divi's Laboratories (-0.34%), Cipla (0.42%), Sun Pharmaceutical Industries (0.72%).The Mutual Fund holding in Orchid Pharma was at 19.43% in 31 Mar 2026. The MF holding has increased from the last quarter. The FII holding in Orchid Pharma was at 0.87% in 31 Mar 2026. The FII holding has decreased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jun 14, 2026, 04:22 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.55
    High volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.28
    Higher than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    -6.65
    Indicates undervaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
847.00
Highest
933.50
52 week range
Lowest
471.30
Highest
898.45
Orchid Pharma News
Orchid Pharma Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Divi's Laboratories
Bullish
6,628.80-0.341,75,426.5378.6111.520.460.01
Cipla
Moderately Bullish
1,388.800.421,12,187.3422.953.870.870.81
Sun Pharmaceutical Industries
Bullish
1,807.250.724,32,524.8536.245.770.920.50
Torrent Pharmaceuticals
Bullish
4,577.000.151,54,232.0367.3217.10.8317.62
Dr Reddy's Laboratories
Bullish
1,273.80-0.101,06,313.6318.633.140.632.34
Mutual Fund Ownership
View all
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 6.29
  • % of AUM 1.45
Kotak Consumption Fund Regular Growth
NA
  • Amount Invested (Cr.) 16.73
  • % of AUM 1.34
Kotak Special Opportunities Fund Regular Growth
NA
  • Amount Invested (Cr.) 25.01
  • % of AUM 1.20
ITI Pharma and Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 2.28
  • % of AUM 1.03
Quant Small Cap Fund Growth
4/5
  • Amount Invested (Cr.) 217.93
  • % of AUM 0.77
Orchid Pharma Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-25Audited Results
2026-02-11Quarterly Results
2025-11-11Quarterly Results
2025-08-12Quarterly Results
2025-05-26Audited Results
About the company Orchid Pharma
  • IndustryBiotechnology & Drugs
  • ISININE191A01027
  • BSE Code524372
  • NSE CodeORCHPHARMA
Orchid Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of formulations and active pharmaceutical ingredients (API). It operates through the pharmaceutical segment. It has a multi-therapeutic presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cardiovascular segment (CVS), nutraceuticals and other oral and sterile products. Its pharmaceutical solutions include active pharmaceutical ingredients (APIs) and finished dosage forms. It offers APIs, including Cephalosporins-Orals, Cephalosporins-Injectables, and Veterinary Products. Its formulations include Cefixime Capsules, Acarbose Tablets, Clozapime Tablets, Clopidogrel Tablets, Desloratadine Tablets and Cefoperazone and Sulbactam for Injection, among others. Its subsidiaries include Orchid Bio-Pharma Limited, Orchid Pharmaceuticals Inc., Bexel Pharmaceuticals Inc. and Diakron Pharmaceuticals, Inc.
  • Management Info
  • Sunil GuptaChief Financial Officer
  • Kapil DayyaCompliance Officer, Company Secretary
  • R. SarangdharVice President, Unit Head - API and FDF
  • Manish DhanukaManaging Director, Executive Director
  • Mridul DhanukaWhole Time Director
  • Srinivasan SHead - CTD and IPM
Orchid Pharma Share Price FAQs

Orchid Pharma is trading at 917.00 as on Fri Jun 12 2026 10:21:59. This is 7.57% upper as compared to its previous closing price of 852.45.

The market capitalization of Orchid Pharma is 4743.59 Cr as on Fri Jun 12 2026 10:21:59.

The average broker rating on Orchid Pharma is Strong Buy. The breakup of analyst rating is given below -

  • 1 analysts have given a strong buy rating
  • 0.00 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Orchid Pharma is 898.45 whereas the 52 wk low is 471.30

Orchid Pharma can be analyzed on the following key metrics -

  • TTM P/E: 122.18
  • Sector P/E: 26.87
  • Dividend Yield: 0.00%
  • D/E ratio: 0.28

Orchid Pharma reported a net profit of 20.55 Cr in 2026.

The Mutual Fund Shareholding was 19.43% at the end of 31 Mar 2026.

Quick Links
EQUITY QUICK LINKS
Orchid Pharma QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Home/Market/Market Stats/  Orchid Pharma share price
✕

Wait for it…

Log in to our website to save your bookmarks. It'll just take a moment.

✕

Wait for it…

Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.